As the basal subtype of human urothelial carcinoma is the most aggressive form of bladder cancer, associated with lower median overall survival (Choi et al., 2014), we sought to determine whether the SHH expression level was associated with clinical outcome in human bladder cancer patients. Here, SHH is linked to urinary bladder cancer.